Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about GILD

Recent news which mentions GILD

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
32 33 Next >
10 Health Care Stocks Whale Activity In Today's Session
Tickers ABBV ALNY CVS GILD
Tags CVS Market News Options
From Benzinga
The 500 Top Stocks to Buy for 2024, Ranked by AI
Tickers AAPL AMD CMG COST
Tags MARA PFE LUV
From InvestorPlace
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,100 Today
Tickers GILD NEWS
Tags GILD Benzinga News
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Tickers CAN EBON GILD HOOK
Tags PARA Top Stories Cryptocurrency
From Benzinga
A Look Into Gilead Sciences Inc's Price Over Earnings
Tickers GILD NEWS
Tags Benzinga GILD BZI/PE
From Benzinga
3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone’
Tickers AMGN GILD VRTX
Tags AMGN VRTX NASDAQ:VRTX,NASDAQ:AMGN,NASDAQ:GILD
From InvestorPlace
Why Is Immunotherapy-Focused Hookipa Pharma Stock Soaring Today?
Tickers GILD HOOK
Tags HOOK Briefs Movers
From Benzinga
Why Is Hookipa Pharma (HOOK) Stock Up 81% Today?
Tickers GILD HOOK MSAI
Tags NASDAQ:HOOK,NASDAQ:GILD,NASDAQ:MSAI MSAI HOOK
From InvestorPlace
RedHill's Investigational COVID-19 Drugs Combined With Gilead's Show Effect Against Ebola
Tickers GILD RDHL
Tags why it's moving General Benzinga
From Benzinga
Why Is Cancer Immunotherapy-Focused Compugen Stock Is Trading Higher Today?
Tickers AZN CGEN GILD
Tags Health Care GILD CGEN
From Benzinga
Why Is Compugen (CGEN) Stock Up 189% Today?
Tickers AZN CGEN GILD MARA
Tags MARA CGEN GILD
From InvestorPlace
(GILD) - Analyzing Gilead Sciences's Short Interest
Tickers GILD
Tags Trading Ideas BZI/SHORTHIST Market News
From Benzinga
Patients Regain Weight After They Quit Using Ozempic Rival Zepbound. Here's Why That Makes Eli Lilly Stock an Even Better Buy.
Tickers GILD LLY NVO
Tags GILD Recent Press Releases LLY
From Motley Fool
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
Tickers ACLX CRSP GILD RVMD
Tags GILD ACLX RVMD
From InvestorPlace
A Bull Market Is Coming: 1 Stock That Could Rocket 219% Higher in 2024, According to Wall Street
Tickers GILD GS IOVA
Tags GS Market News GILD
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers BLUE CERE CI CVS
Tags CERE Benzinga BZI/AUOA
From Benzinga
Gilead Sciences Battles Rising Threat of Drug Counterfeiting, Initiates Legal Actions
Tickers GILD JNJ
Tags GILD Benzinga Legal
From Benzinga
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
Tickers BMY GILD NVS
Tags Market News GILD BMY
From Motley Fool
A Look Into Gilead Sciences Inc's Price Over Earnings
Tickers GILD
Tags GILD Benzinga BZI/PE
From Benzinga
Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy
Tickers CRBU CRSP GILD PFE
Tags Stocks to Buy PFE CRBU
From InvestorPlace
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $11,000 Today
Tickers GILD
Tags Trading Ideas News GILD
From Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making
Tickers ACLX CRSP GILD VRTX
Tags VRTX CRSP Market News
From InvestorPlace
2 Biotech Stocks You Can Buy and Hold for the Next Decade
Tickers GILD SNY
Tags Recent Press Releases GILD SNY
From Motley Fool
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
Tickers BMY GILD JNJ NVS
Tags Benzinga General FDA
From Benzinga
Cabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
Tickers BMY CABA GILD GRCL
Tags BMY NVS GILD
From MarketWatch
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later
Tickers ABBV GILD LLY
Tags ABBV LLY Recent Press Releases
From Motley Fool
Looking Into Gilead Sciences's Recent Short Interest
Tickers GILD
Tags BZI/SHORTHIST Market News Trading Ideas
From Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,000 Today
Tickers GILD
Tags News Trading Ideas GILD
From Benzinga
FDA Approves AstraZeneca's Truqap/Faslodex Combo Therapy For Breast Cancer, Competes With Gilead's Drug
Tickers AZN GILD
Tags Markets Equities Market News
From Benzinga
Gilead Sciences's Options: A Look at What the Big Money is Thinking
Tickers GILD
Tags BZI/UOA GILD Benzinga
From Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.